NYCTEA TECHNOLOGIES

Nyctea Technologies creates purification and administration of Biopharmaceuticals using electronically activated biomolecule control.

#People #Financial #Website #More

NYCTEA TECHNOLOGIES

Social Links:

Industry:
Biotechnology

Founded:
2020-01-01

Address:
Gรถteborg, Vastra Gotaland, Sweden

Country:
Sweden

Website Url:
http://www.nycteatechnologies.com

Total Employee:
1+

Status:
Active

Total Funding:
5.65 K USD

Technology used in webpage:
Viewport Meta Google Font API Google Maps Mobile Optimized One.com Website Builder


Current Employees Featured

not_available_image

Gustav Ferrand-Drake
Gustav Ferrand-Drake Co-Founder, CEO & Member of the board @ Nyctea Technologies
Co-Founder, CEO & Member of the board
2020-10-01

not_available_image

Andreas Dahlin
Andreas Dahlin Co-Founder & Chairman @ Nyctea Technologies
Co-Founder & Chairman

Founder


not_available_image

Andreas Dahlin

not_available_image

Gustav Ferrand-Drake

Investors List

chalmers-ventures_image

Chalmers Ventures AB

Chalmers Ventures AB investment in Pre Seed Round - Nyctea Technologies

Official Site Inspections

http://www.nycteatechnologies.com

  • Host name: webcluster1.webpod12-cph3.one.com
  • IP address: 46.30.213.23
  • Location: Copenhagen Denmark
  • Latitude: 55.6786
  • Longitude: 12.5589
  • Timezone: Europe/Copenhagen
  • Postal: 1052

Loading ...

More informations about "Nyctea Technologies"

Nyctea Technologies

Providing unique and unparalleled electronic control over purification of next gen biopharmaceuticalsSee details»

About - Nyctea Technologies

Nyctea Technologies was founded in 2020 by Gustav Ferrand-Drake del Castillo and professor Andreas Dahlin at Chalmers University of Technology in Sweden. Their research was initially focused on fundamental science, aimed to improve โ€ฆSee details»

Nyctea Technologies - LinkedIn

Nyctea Technologies creates affordable medicine by introducing a new purification technology removing a bottleneck in the manufacturing process that drastically reduces the cost-of-goods.See details»

Technology | Nyctea Technologies

Creating an alternative to chromatography separation, lowering the price of biopharmaceutical production. Creating a new opportunities for implantable drug delivery and microdosing. โ€ฆSee details»

Nyctea Technologies - Crunchbase Company Profile & Funding

Nyctea Technologies creates purification and administration of Biopharmaceuticals using electronically activated biomolecule control. View contacts for Nyctea Technologies to access โ€ฆSee details»

Nyctea Technologies Company Profile 2024: Valuation, โ€ฆ

Developer of a purification technology company designed for biopharmaceutical and protein production. The company's technology manufactures biomolecule purification systems for discovering the biomolecule trapping functionalities of โ€ฆSee details»

Nyctea Technologies - Gรถteborg, Sweden - bionity.com

Jun 22, 2022ย ยท Our mission is to lower the cost and increase the speed of production of biological pharmaceuticals and to accelerate the development of the next generation of medical โ€ฆSee details»

Nyctea Technologies - Chalmers Ventures

The purpose of Nyctea Technologies is to increase the efficiency in the production of biological pharmaceuticals. Antibodies, gene vectors and vaccines are effective treatments against a โ€ฆSee details»

Nyctea Technologies - EU-Startups

Nyctea Technologies was founded in 2020 by PhD student Gustav Ferrand-Drake del Castillo and his supervisor professor Andreas Dahlin at Chalmers University of Technology. Their research was initially focused on fundamental science โ€ฆSee details»

Nyctea Technologies | VentureRadar

Website: https://www.nycteatechnologies.com/ Develops innovative methods for controlling interactions between polyelectrolyte brushes and biomolecules, aiming to reduce costs and โ€ฆSee details»

News | Nyctea Technologies

Nyctea Technologies has been recognized on IVA's prestigious 100 List of Swedish Innovations! ?. Being featured on IVA's 100 List is a testament to Nyctea's innovative spirit and dedication to โ€ฆSee details»

Nyctea Technologies Overview | SignalHire Company Profile

Nyctea Technologies creates purification and administration of Biopharmaceuticals using electronically activated biomolecule control.See details»

Nyctea Technologies โ€“ Funding, Valuation, Investors, News

Http://www.nycteatechnologies.com/ Tags: Analytics BioTech Development Diagnostics Industry Life Manufacturing Pharmacy Production We are providing electronically activated purification โ€ฆSee details»

Nyctea Technologies - VentureRadar

Website: https://www.nycteatechnologies.com/ Nyctea Technologies was founded in 2020 by PhD student Gustav Ferrand-Drake del Castillo and his supervisor professor Andreas Dahlin at โ€ฆSee details»

Nyctea Technologies - VentureRadar

Website: https://www.nycteatechnologies.com/ Develops innovative methods for controlling interactions between polyelectrolyte brushes and biomolecules, aiming to reduce costs and โ€ฆSee details»

Nycteatechnologies - Company Profile - Tracxn

Oct 25, 2024ย ยท Nycteatechnologies ranks 94th among 94 competitors. 8 of its competitors are funded while 13 have exited. Overall, Nycteatechnologies and its competitors have raised over โ€ฆSee details»

News AstraZeneca Collaboration | Nyctea Technologies

Mรถlndal, Sweden, 31-jan-2024. Nyctea Technologies Enters Research Collaboration with AstraZeneca to Enhance Biopharmaceutical Purification . The collaboration leverages โ€ฆSee details»

Nyctea Technologies - Products, Competitors, Financials, โ€ฆ

Nyctea Technologies specializes in the biopharmaceutical sector with a focus on innovating the purification process of biopharmaceuticals. The company offers a technology that enables โ€ฆSee details»

Publications - Nyctea Technologies

Ferrand-Drake et al. Electrically Switchable Polymer Brushes for Protein Capture and Release in Biological Environments. Angew. Chem. Int. Ed. 2022, 61, e202115745 Ferrand-Drake et al. โ€ฆSee details»

Nyctea Competes as Finalist in the BioTools Innovator Capstone โ€ฆ

Nyctea Technologies competed in the BioTools Innovator Capstone final! Out of +400 applicants we made it to the top 4! The competition in the final was fierce with Redbud Labs, Syenex and โ€ฆSee details»

linkstock.net © 2022. All rights reserved